Observational Study
Copyright ©The Author(s) 2024.
World J Crit Care Med. Dec 9, 2024; 13(4): 97631
Published online Dec 9, 2024. doi: 10.5492/wjccm.v13.i4.97631
Table 3 Review of the literature
Ref.
Number of subjects, age, M/F ratio
Study design/HP strategy
Effects on inflammatory markers
Effects on respiratory markers
Main clinical outcomes
Barriga-Moreno et al[19]n = 116, Controls = 84; HP = 32; 57 year (range: 47-71 year); Males: 65%Matched control retrospective Jafron© HA330 cartridgeSerum creatinine (1.4 mg/dL vs 0.5 mg/dL); Serum ferritin (2868 vs 1675)NRMortality rate: 61% in controls (receiving standard care) vs 31% in HP group
Chiewroongroj et al[21]n = 272Matched control retrospective HP patients had less DIC (13% vs 33%; P = 0.046) and less sepsis (38% vs 64%; P = 0.02)HP patients had reduced mechanical ventilation duration (15 days vs 35 days; P < 0.001) and less pulmonary complications (20% vs 42%; P = 0.04)Mortality rates did not differ between the groups (33% vs 38%, P = 0.83)
Controls = 227; HP = 45; 57 year (range: 47-71 year); Males: 65%Jafron© HA330 cartridgeHP group had a significantly shorter ICU stay (22 days vs 32 days; P = 0.017)
Hayanga et al[20]n = 100 (63% male); 44 ± 11 yearMulticenter combination of VV-ECMO and CytoSorb hemoadsorption. Two post hoc groups: Early HP: ≤ 87 hours and late HP > 87 hours Early HP had shorter median duration of mechanical ventilation (7 days)[2-26] than late HP (17 days)[7-37], P = 0.02Survival rates were 86% at 30 days and 74% at 90 days. Earlier HP was associated with shorter need for organ support and ICU stay
Uysal et al[30]55 (34, 61.8%) Mean age 585 ± 12.5 year. Mean (SD), year = 59.6. Male sex, n (%) = 82 (64.1)Case series. Resin-directed Jafron© (HA330) hemadsorption cartridgesFibrinogen, LDH, CRP, and platelets decreased after HPNRIn total, 9 patients (16.4%) survived. Ferritin levels correlated with survival status
Alavi Darazam et al[22]128 (55 HP vs 73 controls). Mean age, (SD), year = 59.6. Male sex, n (%) = 82 (64.1)Matched control retrospective study. Jafron© (HA330) and CytoSorb® 300 cartridgesNRMedian SpO2 statistically higher in HP group than in the controls and median PaCO2 was lowerMortality rate in the HP group significantly lower than controls (67.3% vs 89%; P = 0.002). The median length of ICU stay was 8 days in HP group vs 12 days in controls (P < 0.001)
Mikaeili et al[10] 68 (35 HP vs 33 controls)Prospective studyNRDyspnea decreased significantly in HP groupSignificant mortality rate reduction in HP group compared with controls (37.1% vs 63.6%; P = 0.02)
Mean age: Control 5748 ± 15.63, 18/15; HP group 56.62 ± 15.60, 23/12; sex (M/F): HP group: 32/12; Control: 18/15HA330 D HP for 4 hours, in 3 consecutive days. Early startedSaturation of oxygen (SpO2) and P/F ratio significantly increased after HP unlike the control groupAfter 2 weeks, imagen lung opacities improved in 55% of the patients in HP vs 15.6% in the controls
Surasit et al[11]29 (15 HP vs 14 controls). HP group: 12/15, 54.5 ± 14.4; Control group: 7/7, 64.3 ± 10.2Prospective study. HA-330 3 HP sessions. Early startedExcept for Hb levels (higher in HP group), blood and inflammatory parameters (CRP, ferritin, LDH, CBC) were not statistically differentNRSignificantly lower 28-day mortality rate in HP group compared to control group. Improvement of CXR RALE score and decreased SOFA score in HP group compared to control group
Darban et al[29]40 patients, 57.5 ± 15.9; year 24/16Retrospective cross-sectional study to determine the complications of HP patients with COVID-19 hospitalized in ICUNRNRArrhythmia, bleeding, thrombocytopenia, and coagulation disorders were the most common short-term complications mostly occurring on the second and third days after HP. Mortality occurred in 20 (50%) patients
Peng et al[23]10 patients, median age 677 year (range = 50-85). Sex (male/female): 8/2Case series Cytosorb HP. Median: 3 HPs (range = 1-6)The level of IL-6 significantly decreased after HP. Lactate levels improved after HPSignificant improvement was found in PaO2/FiO2 [118 (81-220) mmHg vs 163 (41-340) mmHg, P = 0.04]Albumin mildly decreased after HP. No significant changes were found in WBC
Abbasi et al[12]37 patients, 55 ± 14.1; year 12/25Retrospective cross-sectional study. Patients divided into three groups: (1) HP without (MV); (2) HP before MV; and (3) HP after MVCRP and ferritin significantly improved after HP in the three groupsHR, RR, and PaO2/FIO2, significantly improved after HP in all groupsNo statistically significant difference between the three groups in terms of length of hospital stay and ICU stay
Soleimani et al[13]48 patients in total. HP cases: 24; Controls: 24Retrospective observational study. HP: HA330 and HA280 filters for four hoursCRP levels decrease in HP patients compared to controlsRR and HR decreased after HP. SpO2 Levels significantly increased after HP. in the and a significant (P = 0.009)HP improved respiratory distress in patients with severe COVID-19 but has no effect on mortality
Alharthy et al[24]50 patients, 50 ± 9; Sex: Male (n, %): 39 (78%)Case seriesNonsurvivors had higher levels of inflammatory biomarkers (CRP, ferritin, and IL-6), and more unresolved shock, ARDSPulmonary emboli more common in non survivorsPosttherapy values of IL-6 predicted in-hospital mortality for critically ill COVID-19 patients. No side effects of therapy were recorded
All received CRRT and CytoSorb. Compared outcomes and biomarkers between survivors (39) and non survivors (11)
Villa et al[25]37 patients, 31/6; 59 ± 9 yearProspective non randomized. Blood purification with AN69ST (oXiris) hemofilterLevels of IL-6 lowered in the first 24 hours of HP. IL-6 levels correlated with organ functionNREarly HP treatment yielded the best outcomes. A slight decrease in observed vs predicted mortality rates observed. No complications reported
Ugurov et al[26]15 patients, 13/2; 60 ± 13 yearCase series; Blood purification using the AN69ST (oXiris) hemofilterCRP (mg/L) pre 109 (73) Decreasing levels of IL-6, IL-8 and TNF-αBlood purification was
associated with decreasing levels of IL-6, IL-8, TNF-α, and CRP
Median intensive care unit length of stay was 9.3 days. 2 out of 15 patients died
Dai et al[27]Treatment group: 40/10, 60 ± 13 year; control group: 35/16, 60 ± 15 yearCase-control multicenter, prospective; Plasma exchange + HP (50 treated + 51 controls)IL-6 Level decreased in the treatment
group and increased in the control group
No statistical differences in the duration of invasive assisted ventilation between the two groupsThe 28-day mortality rates were 16% (8/50) in the treatment group and 50.98% (26/51) in the control group
Hashemian et al[14]14 patients, 9/6; 58 ± 12 yearCase-series Plasmapheresis CytosorbInflammatory mediators (CRP, TNF-, IL-6, and Ferritin) were significantly reduced after plasmapheresis within a weekPlasmapheresis was associated with significant and rapid improvements in oxygenation statusNine out of fifteen patients on NIPPV survived while the six patients undergoing IMV died
De Rosa et al[15]12 patients with COVID-19 + septic shock 9/3; 60 ± 10 yearCase series Polymyxin-B HP (PMX-HP) SOFA score progressively improved over the next 120 hours following PMX-HP and it wasNRCOVID-19 patients with endotoxic shock, PMX-HP was associated with organ function recovery, hemodynamic improvement, and contemporary
EAA level reduction. No PMX-HP-related complications were observed
Asgharpour et al[28]11 patients, 57 ± 18 yearCases series; Tree sessions of extracorporeal resin-directed hemoadsorptionSerum IL-6 and CRP improved after interventionMean SpO2 increased after the three HP sessions Six out of ten patients improved after the intervention
Katagiri et al[16]15 patients, 66 (47) yearCase series ToramixynExcept for one non-survivor, IL-8, IL-10, and IL-17 Levels remained almost unchanged or trended downwardNR25% (NR)
Guo et al[17]17 patients, 62 ± 14 yearCase series 32 cytokines (including IL-6 and TNF-α) out of 34 dosed were significantly decreased after each ALS courseNR100%